Scientific and practical peer-reviewed journal for cardiologists and general practice physicians. Issued since 2005
ISSN 1819-6446 (Print) ISSN 2225-3653 (Online)
Scientific and practical peer-reviewed journal for cardiologists and general practice physicians. Issued since 2005
ISSN 1819-6446 (Print) ISSN 2225-3653 (Online)
Antithrombotic therapy in atrial fibrillation: new data and new horizons
M.Yu. Gilyarov, V.A. Sulimov
I.M. Setchenov First Moscow State Medical University. Trubetskaya ul. 8-2, Moscow, 119991 Russia
New data and perspectives of antithrombotic therapy are highlighted in patients with atrial fibrillation. Factors of warfarin therapy efficacy, as well as the possibility of new antithrombotic drugs are considered. Special attention are paid to the direct thrombin inhibitors — dabigatran. Possibilities and usage prospects of dabigatran in patients with atrial fibrillation are discussed in detail in the light of new results of RE-LY trial.
Key words: atrial fibrillation, anticoagulation, warfarin, dabigatran.
Rational Pharmacother. Card. 2011;7(1):75-81
*Corresponding author: gilarov@rambler.ru
Download free full text (PDF)
© 2007 — 2014 «Rational Pharmacotherapy in Cardiology»
«Stolichnaya Izdatelskaya Kompaniya»
ISSN 1819-6446(Print) ISSN 2225-3653 (Online)
«Stolichnaya Izdatelskaya Kompaniya»
ISSN 1819-6446(Print) ISSN 2225-3653 (Online)